SCHEMBL6989190

SCHEMBL6989190

CC(C)(C)OC(=O)NCCOc1noc2ccc(O)cc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 1/20 0.48
CA12 O43570 5/20 0.46
CA1 P00915 5/20 0.46
CA2 P00918 5/20 0.46
CA9 Q16790 5/20 0.46
CYP1A1 P04798 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2B6 P20813 1/20 0.42
CYP2C19 P33261 1/20 0.42
CYP3A43 Q9HB55 1/20 0.42
BCHE P06276 1/20 0.39
CNR2 P34972 1/20 0.39
PDK2 Q15119 1/20 0.39
SCN9A Q15858 1/20 0.39
MIF P14174 1/20 0.38
IDO1 P14902 2/20 0.38
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
GLA P06280 1/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6993977 0.89 CA12 (0.46) CA12CA1CA2CA9CYP1A1
SCHEMBL6990907 0.88 CA12 (0.45) CA12CA1CA2CA9CYP1A1
SCHEMBL6987623 0.88 CA12 (0.45) CA12CA1CA2CA9CYP1A1
SCHEMBL6992047 0.88 CA12 (0.47) CA12CA1CA2CA9CYP1A1
SCHEMBL6989587 0.88 FAAH (0.49) CA12CA1CA2CA9CYP1A1
SCHEMBL6991751 0.88 CA12 (0.50) NQO2CA12CA1CA2CA9
SCHEMBL6987842 0.87 CA1 (0.44) NQO2CA12CA1CA2CA9
SCHEMBL6990569 0.87 CA12 (0.44) NQO2CA12CA1CA2CA9
SCHEMBL6992097 0.86 CA12 (0.46) CA12CA1CA2CA9CYP1A1
SCHEMBL6989201 0.86 CA12 (0.43) CA12CA1CA2CA9CYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0779281-B1 ISOXAZOLES SANKYO CO (JP) 2003-10-29 EP disclosed
US-6096771-A ISOXAZOLE DERIVATIVES EXHIBITING EXCELLENT TYPE B AND TYPE A MONOAMINE OXIDASE INHIBITORY ACTIVITIES, THEREFORE USEFUL FOR PREVENTING PARKINSON'S DISEASE, DEPRESSION AND ALZHEIMER'S DISEASE SANKYO COMPANY, LIMITED (JP) 2000-08-01 US disclosed
US-5965591-A MONOAMINE OXIDASE INHIBITOR; FOR PROPHYLAXIS AND TREATING PARKINSON'S DISEASE, DEPRESSION AND ALZHEIMER'S DISEASE SANKYO COMPANY, LIMITED (JP) 1999-10-12 US disclosed
EP-0779281-A1 ISOXAZOLES SANKYO COMPANY LIMITED (JP) 1997-06-18 EP disclosed